As a prelude of investigating the mechanism of regression of pressure-overload-induced left ventricular hypertrophy (LVH), we studied the time-course for the development and subsequent regression of LVH as well as accompanying alterations in cardiac function, histology and gene expression. Mice were subjected to aortic banding for 4 or 8 weeks to establish LVH and regression was then initiated by release of aortic banding for a period of 6 weeks. Progressive increase in LV mass, and gradual chamber dilatation and dysfunction occurred following aortic banding. LVH was also associated with myocyte enlargement, interstitial fibrosis, enhanced expression of atrial natriuretic peptide, collagen I, collagen III, and matrix metallopreoteinase-2, but suppressed expression of α-myosin heavy chain and sarcoplasmic reticulum Ca 2+ -ATPase. Aortic debanding completely or partially reversed LVH, chamber dilatation, dysfunction, myocyte size, interstitial fibrosis and gene expression pattern, each with a distinct time-course. The extent of LVH regression was dependent on the duration of pressure overload, evidenced by the fact that restoration of LV structure and function were complete in animals with 4 weeks aortic banding, but incomplete in those who had undergone 8 weeks aortic banding. In conclusion, LVH regression comprises a variety of morphological, functional and genetic components that show distinct time-courses. A longer period of pressure-overload is associated with a slower rate of LVH regression.
INTRODUCTION
Myocardial hypertrophy occurs in response to a variety of biomechanical stimuli. Whilst left ventricular hypertrophy (LVH) in response to increased afterload can be viewed as a compensatory mechanism to maintain cardiac output and normalize wall stress, LVH in the long-term is an independent risk factor for a range of adverse consequences, such as myocardial ischemia, systolic and diastolic dysfunction, arrhythmias and cardiac mortality (4, 9, 18, 19) . Therefore, prevention or regression of LVH is a major therapeutic target whether achieved by pharmacologic, mechanical, surgical or genetic means (11, 21, 27, 35, 38). There has been clinical evidence that regression of LVH reduces morbidity and mortality and improves prognosis (9, 32). For example, both antihypertensive treatment and aortic valvular replacement reverse LV structural, functional and electrophysiological abnormalities (12, 26, 28). Similar benefits have also been observed following drug treatment in different animal models (3, 30) . Although reversal of LVH occurs following control of etiological factors, some studies have revealed incomplete reversal of pathophysiological changes, such as interstitial fibrosis, ventricular remodeling and dysfunction, and aberrant electrophysiology (2, 3, 12) . While numerous clinical and experimental studies have investigated effects of antihypertensive drugs (1, 3) , coronary structure and function (17, 29) , and alteration in gene expression (7, 31, 36) during reversal of LVH, the pathophysiological features and the timecourse of LVH regression are less clearly defined.
Gene-manipulation in the mouse has become a standard approach in heart research providing new insights into molecular and signalling pathways of importance in the development of heart disease (10). Understanding the molecular mechanism of hypertrophy regression through the use of gene-targeted mouse strains require a mouse model of LVH and regression. Although drug-induced hypertrophy and regression murine models have been reported (7, 31), a regression model of pressure-overload-induced hypertrophy is far more AJP H-00836-2004 R3 appealing considering the common use of an aortic constriction model in the mouse. In particular, such a model is not confounded by the use of drugs that may have pressure independent effects. Our hypothesis is that the duration of pressure-overload was a determinant for the degree of LVH regression. Therefore, the aim of this study was to characterise in mice the regression of established LVH induced by transverse aortic banding, the most commonly model. Specifically, we monitored the process of LVH development and regression, together with associated histological and molecular alterations, and also characterized factors that determine the rate of LVH regression. 
RESULTS
Grouping and protocols. Animals surviving AB surgery were allocated into different groups:
10-and 14-week AB, early DB (4-week AB followed by 6-week DB), late DB (8-week AB followed by 6-weeks DB), and 14-week sham-operation. Echocardiography was performed before surgery and at 1, 2, 4, 8, 10, 12 and 14 weeks after surgery for animals with AB and at 1, 4 and 6 weeks after the second surgery for animals with DB, respectively. One additional group of mice with 4-week AB followed by 1-week DB was sacrificed to obtain organ weights and tissues for gene expression analysis.
Features of establishment of LVH. AB resulted in a rapid increase in LV mass with a 79% increment by week 4 but without further increase between 4 to 12 weeks. This was associated with a 37% increase in wall thickness ( Figure 1 ). From 12 to 14 weeks after AB, there was a further 14% increase in LV mass without LV wall thickening ( Figure 1 ). FS was slightly elevated within the first 2 weeks (38±1% at week 2 vs. 35±1% at baseline, P=0.052) but progressively declined thereafter together with a gradual enlargement in LV dimensions after AB ( Figure 1 ). The ratio of h/r increased in the early stage indicating concentric hypertrophy, followed by progressive decline. All the above echocardiographic parameters remained unchanged in sham-operated mice during the 14-week study period. There was no significant difference in heart rate among the groups over the study period (the range of group mean was 360-420 beats/min).
Regression of LVH.
Surgical DB at either 4 or 8 weeks after AB led to a progressive reduction in LV mass during the following 6-week period ( Figure 1 ). Absolute LV mass index was reduced dramatically at 1 week after DB in both early and late DB groups by 72% and 50% of the difference between the sham-operated control and AB values at week 4 or 8, respectively.
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Similar changes in LV wall thickness were observed ( Figure 1 ). Subsequent reduction in LV mass was more gradual. In sharp contrast, recovery of the enlarged LV dimensions and suppressed FS did not occur at 1 week after DB, but were largely complete by 6 weeks after early DB ( Figure 1 ). Reversal of increased LV mass, wall thickness and LV dimension and of decreased FS in the late DB group appeared to be a slower process than in the mice with early DB. This was also reflected by the temporal change in h/r ratio after BD ( Figure 1 ).
Eventually, release of pressure-overload for 6 weeks resulted in a complete normalization of LV mass, LVESd, FS and h/r ratio in mice with early DB, but not in those with late DB ( Figure 1 ).
Hemodynamic assessment.
There was no significant difference in heart rate among the groups (Table) . Compared to sham-operated controls, systolic arterial, LV pressure and pulse pressure were markedly elevated in AB mice confirming pressure overload. After DB, these pressure parameters were normalized and there were no statistical differences compared with sham-operated mice (Table) . Echocardiography-derived LV mass correlated well with actual LV weight, systolic arterial pressure and pulse pressure ( Figure 2 ).
Organ weights and pathological events. Body and organ weights and the incidence of pathological events in mice of various groups are displayed in Table. Body weights were similar among groups. The weights of LV, right ventricle, atria, heart and lungs were markedly higher in mice with AB versus sham-operated group. There was a trend toward a greater degree of hypertrophy in the 14-week AB versus the 10-week AB groups. Autopsyproven heart failure was apparent in AB mice, evidenced by higher incidences of pleural effusion, lung congestion and atrial thrombus. Releasing pressure-overload for a period of 6 weeks led to a restoration of increased LV and heart weights. However, the restoration of organ weights was incomplete in mice with 8-week AB. Whilst mice with 8-week AB did
have greater LV and heart weights versus sham-operated group, there was no significant difference in the LV and heart weights between the earlier DB and sham-operated groups (Table) . (24) and deters onset of early heart failure (14). We also observed an enhanced expression and deposition of collagens by sustained pressure overload, which is associated with increased transcription of MMP-2.
Upregulation of MMPs may act to degrade increased collagen so that to keep a balance of extracellular matrix synthesis and degradation. However, upregulated MMPs may also contribute to the transition from compensated hypertrophy to heart failure (15). In our study, release pressure overload for 1 week had already reversed the altered expression pattern of these genes, which was coupled with regression in LV mass and wall thickness but not in restoration of systolic function and chamber size. Interestingly, rapid regression of hypertrophy and restoration in gene expression seen in our model were also reported in some pharmacological models (7, 31). A previous study showing that many weeks was required for the reversal of altered V3-MHC isozyme in rats with pulmonary artery constriction and followed by DB (13). Thus, although reversal of gene expression is rapid, the slow normalization of these molecules at the protein level might partly be responsible for a delayed function recovery, in conjunction with other factors such as ventricular remodelling and interstitial fibrosis. A slow and incomplete reversal of interstitial fibrosis 6-weeks after DB is not due to continuous overexpression of collagens, but to a slow turnover rate of collagen together with a concomitant decrease in previously elevated expression of MMP.
In conclusion, we have established a regression model of LVH in mice by surgical intervention. Pressure-overload-induced LVH was associated with LV dysfunction, remodelling, myocyte size enlargement, interstitial fibrosis and altered gene expression.
These changes were restored partially or completely after a 6-week period of surgical unloading. In this model, LVH regression involves various morphological, functional and genetic components and each of these displays a distinct time-course. A longer period of pressure-overload is associated with a slower rate of LVH regression. 
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